MY ACCOUNT | NEWSLETTER |

Juvenile hyperinsulinism in a Maine Coon kitten


A 5.5 month-old intact male Maine Coon cat was presented to a referral hospital for a history of muscle fasciculations, lethargy and seizures associated with refractory hypoglycemia. 

Diagnostic testing for hypothyroidism, hyposomatotropism or hypoadrenocorticism, inborn errors of metabolism (i.e., storage diseases and urea cycle disorders), infection or iatrogenic hypoglycemia were negative. An inappropriately high serum insulin level was noted in the face of marked hypoglycemia. The insulin:glucose ratio was 0.44 (<0.3) and the amended insulin:glucose ratio was 1268 (<30). 

Thoracic radiography and abdominal ultrasonography did not identify a cause for this elevated insulin level. Stabilization with a low, but adequate, blood glucose occurred with corticosteroid therapy, with further significant improvement with the addition of diazoxide. 

Peripheral neuropathy developed several months later, and concerns for quality of life led to humane euthanasia approximately one year after the initial diagnosis. Insulin levels remained high at the time of euthanasia. 

Necropsy found no gross lesions, though microscopic degeneration of the sciatic nerve and subjectively mild increased size and number of pancreatic islets was noted. These findings were consistent with a diagnosis of congenital hyperinsulinism.

The authors concluded that this is the first reported case of congenital hyperinsulinism in a cat and may parallel the diffuse form of hypoglycemic hyperinsulinism reported in humans and a single dog. It should be considered a differential diagnosis in kittens presenting for refractory hypoglycemia.

Matthew Kornya, et al. “Juvenile hyperinsulinism in a Maine Coon kitten.” Journal of Feline Medicine and Surgery Open Reports. 23 November 2022; 8(2). doi.org/10.1177/20551169221136473

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Trends in fluoroquinolone resistance of bacteria isolated from canine urinary tracts

Like0
Dislike0

Teaching Transrectal Palpation of the Internal Genital Organs in Cattle

Like0
Dislike0

Male embryos grow faster: Breakthrough study reveals genetic reasons why

Like0
Dislike0

CityVet Recognized Among Fortune’s 2025 Best Workplaces in Health Care™ and Earns Great Place To Work® Certification for the Third Year in a Row

Like0
Dislike0

Innovations in veterinary markets: opinion leaders' social capital

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top